PDCD1LG2 and neoplasm: Although the functional implications of the novel interaction between PD-L1 and PD-L2 in immune response and cancer checkpoint activity remain to be determined, both of these PD-1 ligands can in some circumstances be co-expressed by tumour cells, as exemplified by expression studies on Reed–Sternberg cells in Hodgkin's lymphomas37.